Endotoxin and CD14 in the progression of biliary atresia

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Chou, Ming Huei ^a,b   Chuang, Jiin Haur ^b,c   Eng, Hock Liew ^c   Chen, Ching Mei ^c   Wang, Chiou Huey ^d   Chen, Chao Long ^c   Lin, Tsun Mei ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; ALANINE AMINOTRANSFERASE; BILIRUBIN; LIPID A; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT ATRESIA; BILE DUCT LIGATION; CLINICAL ARTICLE; COMMON BILE DUCT CYST; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER INJURY; LIVER TRANSPLANTATION; MALE; NONHUMAN; OUTPATIENT DEPARTMENT; PATHOGENESIS; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INFANT; LIVER; METABOLISM; PATHOLOGY; SOLUBILITY; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD14; BILIARY ATRESIA; BILIRUBIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTOXINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; LIPID A; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SOLUBILITY;

EID: 78650273148     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-138     Document Type: Article

References (44)

1. Bassett MD, Murray KF. Biliary atresia: recent progress. J Clin Gastroenterol 2008, 42:720-729. 10.1097/MCG.0b013e3181646730, 18496390.
2. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009, 374:1704-1713. 10.1016/S0140-6736(09)60946-6, 19914515.
3. Wadhwani SI, Turmelle YP, Nagy R, Lowell J, Dillon P, Shepherd RW. Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. Pediatrics 2008, 121:e1438-1440. 10.1542/peds.2007-2709, 18443020.
4. Reyes H, Zapata R, Hernandez I, Gotteland M, Sandoval L, Jiron MI, Palma J, Almuna R, Silva JJ. Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy?. Hepatology 2006, 43:715-722. 10.1002/hep.21099, 16557543.
5. Marpegan L, Leone MJ, Katz ME, Sobrero PM, Bekinstein TA, Golombek DA. Diurnal variation in endotoxin-induced mortality in mice: correlation with proinflammatory factors. Chronobiol Int 2009, 26:1430-1442. 10.3109/07420520903408358, 19916840.
6. Andonegui G, Zhou H, Bullard D, Kelly MM, Mullaly SC, McDonald B, Long EM, Robbins SM, Kubes P. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest 2009, 119:1921-1930. 2701859, 19603547.
7. Neyrinck AM, Taper HS, Gevers V, Declerck B, Delzenne NM. Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J Hepatol 2002, 36:466-473. 10.1016/S0168-8278(02)00009-0, 11943416.
8. Klintman D, Li X, Santen S, Schramm R, Jeppsson B, Thorlacius H. p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 2005, 242:830-838. discussion 838-839, 10.1097/01.sla.0000189132.86878.f7, 1409872, 16327493.
9. Ramnath RD, Ng SW, Guglielmotti A, Bhatia M. Role of MCP-1 in endotoxemia and sepsis. Int Immunopharmacol 2008, 8:810-818. 10.1016/j.intimp.2008.01.033, 18442784.
10. Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver Int 2006, 26:559-565. 10.1111/j.1478-3231.2006.01255.x, 16762000.
11. Lin YF, Lee HM, Leu SJ, Tsai YH. The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively. J Cell Biochem 2007, 102:429-441. 10.1002/jcb.21305, 17455194.
12. Nicu EA, van der Velden U, Everts V, Loos BG. Expression of FcgammaRs and mCD14 on polymorphonuclear neutrophils and monocytes may determine periodontal infection. Clin Exp Immunol 2008, 154:177-186. 10.1111/j.1365-2249.2008.03751.x, 2612716, 18782328.
13. Zhao Z, Fleming R, McCloud B, Klempner MS. CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi. Infect Immun 2007, 75:3062-3069. 10.1128/IAI.00202-07, 1932873, 17403874.
14. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004, 172:4470-4479.
15. Ahmed AF, Nio M, Ohtani H, Nagura H, Ohi R. In situ CD14 expression in biliary atresia: comparison between early and late stages. J Pediatr Surg 2001, 36:240-243. 10.1053/jpsu.2001.20063, 11150474.
16. Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis. Pediatrics 2005, 116:437-441. 10.1542/peds.2004-1900, 16061600.
17. Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, Wheeler MD. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1318-1328. 10.1152/ajpgi.00405.2005, 16439470.
18. Von Hahn T, Halangk J, Witt H, Neumann K, Muller T, Puhl G, Neuhaus P, Nickel R, Beuers U, Wiedenmann B, Berg T. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease. Scand J Gastroenterol 2008, 43:584-592. 10.1080/00365520701806065, 18415752.
19. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002, 283:G256-265.
20. Su GL, Goyert SM, Fan MH, Aminlari A, Gong KQ, Klein RD, Myc A, Alarcon WH, Steinstraesser L, Remick DG, Wang SC. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am J Physiol Gastrointest Liver Physiol 2002, 283:G640-645.
21. Pan Z, Zhou L, Hetherington CJ, Zhang DE. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. J Biol Chem 2000, 275:36430-36435. 10.1074/jbc.M003192200, 10960472.
22. Su GL, Dorko K, Strom SC, Nussler AK, Wang SC. CD14 expression and production by human hepatocytes. J Hepatol 1999, 31:435-442. 10.1016/S0168-8278(99)80034-8, 10488701.
23. Wilkinson DG. RNA detection using non-radioactive in situ hybridization. Curr Opin Biotechnol 1995, 6:20-23. 10.1016/0958-1669(95)80004-2, 7534503.
24. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995, 270:5320-5325. 10.1074/jbc.270.10.5320, 7534294.
25. Kitchens RL, Munford RS. CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 1998, 160:1920-1928.
26. Liu S, Khemlani LS, Shapiro RA, Johnson ML, Liu K, Geller DA, Watkins SC, Goyert SM, Billiar TR. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 1998, 66:5089-5098. 108634, 9784508.
27. Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 1995, 109:1969-1976. 10.1016/0016-5085(95)90765-3, 7498663.
28. Su GL, Rahemtulla A, Thomas P, Klein RD, Wang SC, Nanji AA. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease. Am J Pathol 1998, 152:841-849. 1858404, 9502426.
29. Tracy TF, Fox ES. CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 1995, 118:371-377. 10.1016/S0039-6060(05)80347-2, 7543706.
30. Zuo GQ, Gong JP, Liu CA, Li SW, Wu XC, Yang K, Li Y. Expression of lipopolysaccharide binding protein and its receptor CD14 in experimental alcoholic liver disease. World J Gastroenterol 2001, 7:836-840.
31. Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, Tilg H. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 2002, 22:380-387. 10.1034/j.1600-0676.2002.01666.x, 12390473.
32. Roughneen PT, Drath DB, Kulkarni AD, Rowlands BJ. Impaired nonspecific cellular immunity in experimental cholestasis. Ann Surg 1987, 206:578-582. 10.1097/00000658-198711000-00004, 1493297, 2823730.
33. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1998, 29:409-416. 10.1016/S0168-8278(98)80058-5, 9764987.
34. Lee JW, Paape MJ, Elsasser TH, Zhao X. Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infect Immun 2003, 71:4034-4039. 10.1128/IAI.71.7.4034-4039.2003, 161972, 12819092.
35. Chuang JH, Chou MH, Wu CL, Du YY. Implication of innate immunity in the pathogenesis of biliary atresia. Chang Gung Med J 2006, 29:240-250.
36. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005, 11:225-229.
37. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995, 181:857-866. 10.1084/jem.181.3.857, 2191937, 7532683.
38. Fearns C, Loskutoff DJ. Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 1997, 65:4822-4831. 175692, 9353071.
39. Li SW, Gong JP, Wu CX, Shi YJ, Liu CA. Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia. World J Gastroenterol 2002, 8:124-127.
40. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA 1998, 95:13875-13880. 10.1073/pnas.95.23.13875, 24941, 9811894.
41. Landmann R, Reber AM, Sansano S, Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 1996, 173:661-668.
42. Schutt C, Schilling T, Grunwald U, Stelter F, Witt S, Kruger C, Jack RS. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14. Res Immunol 1995, 146:339-350. 10.1016/0923-2494(96)81038-8, 8719658.
43. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000, 46:725-731. 10.1136/gut.46.5.725, 1727939, 10764720.
44. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 2005, 28:886-892. 10.1248/bpb.28.886, 15863899.